Novartis/Amgen’s migraine drug excites with phase 3 data
Erenumab under review in US and EU
X
Novartis/Amgen’s migraine drug excites with phase 3 data
https://pharmaphorum.com/news/novartisamgen/
Teva
New Teva CEO axes R&D chief Hayden in boardroom shakeup
R&D chief Michael Hayden to leave at year end.
GSK seeks COPD approval for mepolizumab
GSK looks to build on mepolizumab’s success in asthma
Judge throws out Allergan patents, criticises Native American tribe deal
Federal court throws out patents on Restasis
Copaxone first on FDA’s list for faster complex generic approvals
Teva will attempt to block generic launch in courts
Huntington’s Disease wearable gets backing from NIH
BioSensics’ HDWear provides real-time motor function scores in Huntington’s patients.
Teva appoints Lundbeck’s Kare Schultz as CEO
Unlike AZ’s Soriot, Schultz “couldn’t refuse” top job at Teva.
Bidders lining up for Teva women’s health unit
Allergan generics buyout left Teva with $35m debts